Researcher Profile

Guare, EG, Hale, CM, Sivik, J, Lehman, E, Inoue, Y, Rakszawski, K, Songdej, N, Nickolich, M, Zheng, H, Naik, S, Claxton, D, Rybka, W, Hohl, R, Mineishi, S, Minagawa, K & Paules, CI 2024, 'The addition of doxycycline to fluoroquinolones for bacterial prophylaxis in autologous stem cell transplantation for multiple myeloma', Transplant Infectious Disease, vol. 26, no. 2, e14241. https://doi.org/10.1111/tid.14241

Jia, B, Zhao, C, Minagawa, K, Shike, H, Claxton, DF, Ehmann, WC, Rybka, WB, Mineishi, S, Wang, M, Schell, TD, Prabhu, KS, Paulson, RF, Zhang, Y, Shultz, LD & Zheng, H 2023, 'Acute Myeloid Leukemia Causes T Cell Exhaustion and Depletion in a Humanized Graft-versus-Leukemia Model', Journal of Immunology, vol. 211, no. 9, pp. 1426-1437. https://doi.org/10.4049/jimmunol.2300111

Cioccio, J, Rakszawski, K, Zheng, H, Nickolich, M, Naik, S, Wirk, B, Rybka, W, Ehmann, C, Silar, B, Vajdic, C, Shah, N, Tuanquin, L, Greiner, R, Brown, V, Hohl, R, Claxton, D, Mineishi, S, Minagawa, K & Shike, H 2023, 'Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis', Annals of Hematology, vol. 102, no. 3, pp. 613-620. https://doi.org/10.1007/s00277-022-05077-2

Shah, N, Cioccio, J, Rakszawski, K, Zheng, H, Nickolich, M, Naik, S, Wirk, B, Rybka, W, Ehmann, C, Silar, B, Vajdic, C, Mierski, J, Zhou, S, Shike, H, Greiner, R, Brown, V, Hohl, R, Claxton, D, Mineishi, S, Minagawa, K & Tuanquin, L 2022, 'Low-dose total body irradiation promotes T-cells donor chimerism in reduced-intensity/non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide', Leukemia Research, vol. 123, 106969. https://doi.org/10.1016/j.leukres.2022.106969

Pizzola, CJ, Cioccio, J, Rakszawski, KL, Nickolich, M, Ehmann, WC, Rybka, WB, Wirk, B, Naik, S, Zheng, H, Silar, B, Shike, H, Zhou, S, Mineishi, S, Minagawa, K & Claxton, DF 2022, 'Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbidities', Bone Marrow Transplantation, vol. 57, no. 11, pp. 1743-1745. https://doi.org/10.1038/s41409-022-01821-4

Gregory, GP, Kumar, S, Wang, D, Mahadevan, D, Walker, P, Wagner-Johnston, N, Escobar, C, Bannerji, R, Bhutani, D, Chang, J, Hernandez-Ilizaliturri, FJ, Klein, A, Pagel, JM, Rybka, W, Yee, AJ, Mohrbacher, A, Huang, M, Farooqui, M, Marinello, P & Quach, H 2022, 'Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study', Blood Advances, vol. 6, no. 4, pp. 1232-1242. https://doi.org/10.1182/bloodadvances.2021005872

Zhao, C, Bartock, M, Jia, B, Shah, N, Claxton, DF, Wirk, B, Rakszawski, KL, Nickolich, MS, Naik, SG, Rybka, WB, Ehmann, WCC, Hohl, RJ, Valentin, J, Bernas-Peterson, M, Gerber, EM, Zimmerman, M, Mierski, JA, Mineishi, S & Zheng, H 2022, 'Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant', Journal of Hematology and Oncology, vol. 15, no. 1, 64. https://doi.org/10.1186/s13045-022-01287-3

Percival, ME, Wang, HL, Zhang, MJ, Saber, W, de Lima, M, Litzow, M, Kebriaei, P, Abdel-Azim, H, Adekola, K, Aljurf, M, Bacher, U, Badawy, SM, Beitinjaneh, A, Bejanyan, N, Bhatt, V, Byrne, M, Cahn, JY, Castillo, P, Chao, N, Chhabra, S, Copelan, E, Cutler, C, DeFilipp, Z, Dias, A, Diaz, MA, Estey, E, Farhadfar, N, Frangoul, HA, Freytes, CO, Gale, RP, Ganguly, S, Gowda, L, Grunwald, M, Hossain, N, Kamble, RT, Kanakry, CG, Kansagra, A, Kharfan-Dabaja, MA, Krem, M, Lazarus, HM, Lee, JW, Liesveld, JL, Lin, R, Liu, H, McGuirk, J, Munker, R, Murthy, HS, Nathan, S, Nishihori, T, Olsson, RF, Palmisiano, N, Passweg, JR, Prestidge, T, Ringdén, O, Rizzieri, DA, Rybka, WB, Savoie, ML, Schultz, KR, Seo, S, Sharma, A, Solh, M, Strair, R, van der Poel, M, Verdonck, LF, Yared, JA, Weisdorf, D & Sandmaier, BM 2021, 'Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation (Bone Marrow Transplantation, (2021), 56, 9, (2108-2117), 10.1038/s41409-021-01261-6)', Bone Marrow Transplantation, vol. 56, no. 9, pp. 2319. https://doi.org/10.1038/s41409-021-01353-3

Percival, ME, Wang, HL, Zhang, MJ, Saber, W, de Lima, M, Litzow, M, Kebriaei, P, Abdel-Azim, H, Adekola, K, Aljurf, M, Bacher, U, Badawy, SM, Beitinjaneh, A, Bejanyan, N, Bhatt, V, Byrne, M, Cahn, JY, Castillo, P, Chao, N, Chhabra, S, Copelan, E, Cutler, C, DeFilipp, Z, Dias, A, Diaz, MA, Estey, E, Farhadfar, N, Frangoul, HA, Freytes, CO, Gale, RP, Ganguly, S, Gowda, L, Grunwald, M, Hossain, N, Kamble, RT, Kanakry, CG, Kansagra, A, Kharfan-Dabaja, MA, Krem, M, Lazarus, HM, Lee, JW, Liesveld, JL, Lin, R, Liu, H, McGuirk, J, Munker, R, Murthy, HS, Nathan, S, Nishihori, T, Olsson, RF, Palmisiano, N, Passweg, JR, Prestidge, T, Ringdén, O, Rizzieri, DA, Rybka, WB, Savoie, ML, Schultz, KR, Seo, S, Sharma, A, Solh, M, Strair, R, van der Poel, M, Verdonck, LF, Yared, JA, Weisdorf, D & Sandmaier, BM 2021, 'Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation', Bone Marrow Transplantation, vol. 56, no. 9, pp. 2108-2117. https://doi.org/10.1038/s41409-021-01261-6

Shah, N, Rakszawski, K, Nickolich, M, Ehmann, C, Wirk, B, Naik, S, Rybka, W, Zheng, H, Mierski, J, Silar, B, Mackey, G, Greiner, R, Brown, V, Claxton, D, Mineishi, S & Minagawa, K 2021, 'Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion', Annals of Hematology, vol. 100, no. 10, pp. 2585-2592. https://doi.org/10.1007/s00277-021-04616-7

Luger, SM, Wang, VX, Rowe, JM, Litzow, MR, Paietta, E, Ketterling, RP, Lazarus, H, Rybka, WB, Craig, MD, Karp, J, Cooper, BW, Makary, AZ, Kaminer, LS, Appelbaum, FR, Larson, RA & Tallman, MS 2021, 'Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial', Leukemia Research, vol. 111, 106736. https://doi.org/10.1016/j.leukres.2021.106736

Gvozdjan, K, Casey, H, Mowery, C, Kumer, L, Fisher, C, Tyler, J, Bayerl, MG, Malysz, J, Naik, S, Rybka, W, Ehmann, C, Claxton, D, Mineishi, S, Baker, M, Hong, Z & Shike, H 2021, 'Unexpected Short-Tandem-Repeat Patterns in Post-Transplant Chimerism Testing: Investigation of 3 Cases with Help from Forensic Science', Laboratory Medicine, vol. 51, no. 6, pp. 635-641. https://doi.org/10.1093/LABMED/LMAA022

Strickland, SA, Wang, XV, Cerny, J, Rowe, JM, Rybka, W, Tallman, MS, Litzow, M & Lazarus, HM 2020, 'A novel PrECOG (PrE0901) dose-escalation trial using eltrombopag: enhanced platelet recovery during consolidation therapy in acute myeloid leukemia', Leukemia and Lymphoma, vol. 61, no. 9, pp. 2191-2199. https://doi.org/10.1080/10428194.2020.1762878

Zheng, H, Mineishi, S, Claxton, D, Zhu, J, Zhao, C, Jia, B, Ehmann, WC, Rybka, WB, Naik, S, Songdej, N, Drabick, JJ & Hohl, RJ 2021, 'A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia', American Journal of Hematology, vol. 96, no. 2, pp. E46-E50. https://doi.org/10.1002/ajh.26043